治疗低风险和中等风险的急性肌肉细胞白血病,有或没有化疗:在第三级护理中心的比较
Mohit Saxena1, Irappa V Madabhavi2, Apurva Patel3
1Department of Medical Oncology, Narayana Superspeciality Hospital, Gurgaon, Delhi, India.
Journal of cancer research and therapeutics
|October 3, 2023
概括
全跨网红酸和三氧化物 (ATRA-ATO) 与ATRA和化疗一样有效且毒性更低,用于治疗低至中等风险的急性肌肉细胞白血病 (APL). 这种组合为APL患者提供了可行的治疗选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 急性肌肉细胞白血病 (APL) 约占急性肌肉细胞白血病 (AML) 病例的10%.
- APL是一种独特的亚型,需要特定的治疗策略.
研究的目的:
- 为了比较两种治疗方案的疗效和毒性,用于低风险和中等风险的APL.
- 为了评估全转网红酸和三氧化 (ATRA-ATO) 与ATRA和化疗.
主要方法:
- 一项研究包括30名新诊断的低风险和中等风险APL的患者.
- 15名患者接受了ATRA-ATO,而其他15名患者接受了ATRA和化疗.
- 患者被跟踪至少2年.
主要成果:
- 讨论了两种治疗方案,患者提供了知情同意.
- 30名新诊断的低风险和中等风险APL患者符合纳入标准.
- 15名患者接受了ATRA-ATO,15名患者接受了ATRA和化疗.
结论:
- 在低风险和中等风险的APL中,ATRA和ATO的组合同样有效,并且比ATRA和化疗更少毒性.
- 对于这种患者,ATRA-ATO是一种可行且可行的治疗选择,特别是在资源有限的环境中.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.4K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352
